CAS: 197525-99-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TRAM 39 REF: IN-DA01ENNCCAS: 197525-99-8 | 99% | To inquire | Tue 15 Oct 24 |
 | TRAM 39 REF: 3D-XHA52599CAS: 197525-99-8 | Min. 95% | To inquire | Mon 25 Nov 24 |
 | TRAM 39 REF: TM-T23471CAS: 197525-99-8 | 99.51% | 36.00 €~1,095.00 € | Mon 02 Dec 24 |
Ref: IN-DA01ENNC
| 5mg | 179.00 € | ||
| 10mg | 339.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 15 Oct 2024
TRAM 39
CAS:197525-99-8
TRAM-39 is a drug that affects the endothelial function in the carotid arteries. It has …
Formula:
C20H14ClN
Purity:
Min. 95%
Molecular weight:
303.8 g/mol
Ref: 3D-XHA52599
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 25 Nov 2024
TRAM 39
CAS:197525-99-8
TRAM 39 (2-Chloro-α,α-diphenylbenzeneacetonitrile) is a selective blocker of intermediate-conductance Ca2+-activated K+channels.
Formula:
C20H14ClN
Purity:
99.51%
Color and Shape:
Solid
Molecular weight:
303.78
Ref: TM-T23471
| 5mg | 45.00 € | ||
| 10mg | 69.00 € | ||
| 25mg | 126.00 € | ||
| 50mg | 194.00 € | ||
| 100mg | 307.00 € | ||
| 200mg | 429.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
